Diagnostic Value of Homocysteine Metabolic Pathway in Coronary Atherosclerosis: A Study on Reference Intervals and Risk Prediction

同型半胱氨酸代谢途径在冠状动脉粥样硬化诊断中的价值:参考区间和风险预测研究

阅读:1

Abstract

PURPOSE: To determine the reference intervals of homocysteine (Hcy) metabolic pathway in healthy adults using direct continuous sampling, and to explore their correlations with coronary atherosclerosis (CA) for improving the risk assessment and diagnostic accuracy of CA. PATIENTS AND METHODS: A total of 426 reference individuals were selected via direct continuous sampling of the two centers from healthy adults based on questionnaires and laboratory indicators. Additionally, 75 patients were diagnosed with CA by cardiologists. Standardized analysis of Hcy, cysteine (Cys) and methionine (Met) levels in serum were conducted using commercial assay kits compatible with LC-MS/MS. RESULTS: Although Met and Hcy showed significant differences between the sexes, they could not meet the criteria for setting reference intervals. After outlier removal and normality conversion, 95% reference intervals of Hcy, Cys and Met were calculated as 7-25 μmol/L, 227-410 μmol/L, and 21-39 μmol/L, respectively. In addition, the correlations among Hcy, Cys, and Met were influenced by CA, and each served as an independent risk factor. The area under the curve (AUC) for the combined three indicators increased to 0.86 (95% CI: 0.81-0.91). The specificity increased to 83%, while the sensitivity reached 78%. CONCLUSION: The Hcy metabolic pathway significantly enhances risk assessment capability and may be helpful in providing reference values for the diagnosis and risk prediction of CA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。